Studien
Name
Partner
Indikation
Kurztitel
Wirkstoff
Status
BGB-3111-306
Bei Gene
Mantelzell-Lymphom elderly (>60 Y)
open-label, multicenter study, Zanubrutinib + R vs. R+B
Zanubrutinib
offen
COPA-R-CHOP
DLBCL 1st line
R-CHOP + Copa
Copanlisib
offen
GO29781
Roche/Genentech
relapsed oder refraktär NHL/CLL
Mosunetuzumab mono vs Mosunetuzumab mit Atezolizumab
BTCT4465A u Atezolizumab
offen, Slotanfrage
NIVEAU
DLBCL rez.
R-GemOx +/- Nivolumab
Nivolumab
offen
AERN
HD rez.
Nivolumab
offen
MCL Register
MCL
GLA Lymphome
follikuläre Lymphome & MZL
GAZAI
FL Frühstadien
Obinutuzumab + 4Gy
Obinutuzumab + 4Gy
offen
ALTERNATIVE C
FL 1. Linie
Obinutuzumab + Copanlisib
Copanlisib
offen
COUP-1
Uniklinik Ulm
Marginalzonen-Lymphom
Primärtherapie
Copanlisib (IMP) + Ritux
offen
PAVO CCTL019A2205B
Novartis
Ref./ Relapsed Follicular Lymphoma
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy
CTL019 (tisagenlecleucel)
Initiierung hat stattgefunden
CHARLY Trial
Lymphom Non-Hodgkin
Haploident. Transplantation
Cyclophosphamid
offen
GHSG _ Allo bei HL
Hodgkin Lymphom / Transplantation
posttransplantations Strategien
Brentuximab in Erhaltung + Konsolidierung
offen
Aaron
Ref./ Relaps. New diagn. AML
Relatlimab with Nivolumab in Comb. 5-Azacytidine by relapsed / refractory or newly diagnosed AML
Relatlimab + Nivolumab + 5-Azacitidine
in Einreichung
AMG330 (20120252)
Amgen
AML
Rezidiv-Monotherapie, MRD-Kohorte
AMG330
offen, Slotanfrage
AMG673
Amgen
AML (relapsed/refractory)
AMG 673 Administered as Short Term Intravenous Infusion
offen
BLAST Halle
AML
Cytarabin + BL 8040 vs. Placebo
BL 8040
offen
WP2004
F. Hoffmann- La. Roche LTD
AML hematologic and molecular relapse
DOSE ESCALATION OF RO7283420 IN AML
bispez. AK
offen (Greenlight ab 24.08.2021)
IMCgp (immunocore)
Immunocore
Uveales Melanom
IMCgp100 vs Investigator choice
IMCgp100
offen
EWALL BOLD
Universität Frankfurt
ALL
Blinatumomab
offen
TRANSCEND JCAR017 BCM-001
Celgene / BMS
aggr. B-Zell NHL
CAR-T-Cells bei aggr. B-Zell Lymphom
JCAR017
offen, Sponsor meldet Slots
AMG 427
Amgen
AML (FLAG 3 pos)
Bite AK (Flag 3) short term infus.
AMG 427
offen
TEAM-Trial
AML
Acute Myeloid Leukemia
Borte+Cyta+Gemtu+Pegfilg.
offen
APOLLO
Universität Dresden
APL
ATO/ATRA
ATO/ATRA
offen
BIBF 1120
AML
safety and efficacy of nintendanib
Nintendanib
offen
GMALL Register
Universität Frankfurt
ALL
offen
GMALL 08/2013 (Prof. Spiekermann)
Universität Frankfurt
ALL/LBL
Therapieoptimierung
Nelarabin
offen
CML Register (CML VI)
Universität Heidelberg
CML
Register
offen
AML Register
Universität Münster
AML
Register
offen
HD21
Uniklinik Köln
HD
offen für +61 Jahre
COVIM
Charité Berlin
Covid19-Impfstudie
offen
DSMMXVII
MM 1st line
Elotuzumab, Carfilzomib, Lenalidomit, Dexamethason
Elotuzumab
offen
JCAR-017-FOL-001
Celgne / BMS
Refractory indolent B-Cell- Non-Hodgin Lymphome
Car-T-Cell
Car-T-Cell
offen
TRACE
CMV, EBV and AdV
Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation
offen
